AMEX · Financial Statements
Heat Biologics, Inc. (HTBX) Financial Statements
$2.38
AMEX: HTBX
Market Cap $61.07M
Overview Financials Dividend Heat Biologics, Inc. most recently reported annual revenue of $2.0M, a net loss of $35.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $2.0M $6.0M $3.0M $3.0M $2.0M Operating Profit $-13.0M $-18.0M $-21.0M $-26.0M $-35.0M Net Profit $-12.0M $-16.0M $-20.0M $-26.0M $-35.0M EPS $-21.56 $-6.30 $-4.21 $-1.63 $-1.41 Op Margin -877.9% -310.0% -680.4% -886.2% -1676.4%
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $20.0M $38.0M $26.0M $124.0M $121.0M Total Liabilities $14.0M $8.0M $13.0M $9.0M $9.0M Cash $10.0M $22.0M $9.0M $11.0M $8.0M Borrowings $0 $0 $2.0M $2.0M $2.0M
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $-6.0M $-22.0M $-13.0M $-22.0M $0 Investing Cash Flow $-1.0M $-7.0M $-1.0M $-96.0M $0 Financing Cash Flow $9.0M $40.0M $0 $119.0M $0 Net Cash Flow $2.0M $12.0M $-13.0M $2.0M $0 Free Cash Flow $-6.0M $-22.0M $-13.0M $-22.0M $0
Valuation & Return Ratios
Metric Value PEG Ratio 0.18 EV / EBITDA -3.72 FCF Yield -15967652.00% Quick Ratio -0.01 Interest Coverage 8.52 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .